Skip to main content
Year archive

CAMBIUM BIO LIMITED — 2021 filings

All 43 regulatory filings released by CAMBIUM BIO LIMITED (CMB) in 2021, sourced directly from the official regulator.

43 Filings
2021 Period
2021 filings (43)
Filing Released Lang
Regeneus Market Update 3 pages 147.0KB
Capital/Financing Update
2021-12-21 English
Chairman's Address to Shareholders 3 pages 172.4KB
AGM Information
2021-11-17 English
Results of Annual General Meeting 2 pages 174.7KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-17 English
Supplementary Announcement - Appendix 4C 6 pages 342.5KB
Interim / Quarterly Report
2021-11-16 English
Amendment to Institutional Placement 1 page 138.5KB
Capital/Financing Update
2021-11-04 English
Investor Update Webcast - November 2021 1 page 118.
Investor Presentation
2021-11-04 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 336.6KB
Interim / Quarterly Report
2021-10-28 English
Regeneus Corporate Presentation (October 2021) 27 pages 1.3MB
Investor Presentation
2021-10-27 English
Annual Report 2021 64 pages 6.9MB
Regulatory Filings
2021-10-25 English
Appendix 4G and Corporate Governance Statement 26 pages 414.4KB
Governance Information
2021-10-25 English
Revised Securities Trading Policy 9 pages 233.9KB
Governance Information
2021-10-25 English
Regeneus Company Update Investor Webcast Presentation 1
Regulatory Filings
2021-10-24 English
Notice of Annual General Meeting / Proxy / Question Form 28 pages 635.0KB
AGM Information
2021-10-14 English
Virtual Annual General Meeting Online Guide 5 pages 1.6MB
AGM Information
2021-10-14 English
Cleansing Statement 1 page 693.6KB
Capital/Financing Update
2021-10-13 English
Application for quotation of securities - RGS 6 pages 27.8KB
Share Issue/Capital Change
2021-10-13 English
Revised Date of AGM 1 page 440.1KB
AGM Information
2021-09-19 English
Appendix 4E - Preliminary final report-unaudited 11 pages 1.0MB
Annual Report
2021-08-30 English
Date of AGM 1 page 441.6KB
AGM Information
2021-08-18 English
Lapse of Unlisted Share Options 1 page 131.7KB
Capital/Financing Update
2021-08-08 English
Notification of cessation of securities - RGS 4 pages 24.2KB
Regulatory Filings
2021-08-08 English
Lapse of Unlisted Share Options - correction 1 page
Share Issue/Capital Change
2021-08-08 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 329.7KB
Interim / Quarterly Report
2021-07-28 English
R&D Collaboration with Kolling Institute 2 pages 311.4KB
Regulatory Filings
2021-07-27 English
Company Secretary Appointment/Resignation 1 page 12
Board/Management Information
2021-06-29 English
Cleansing Statement 1 page 93.4KB
Capital/Financing Update
2021-05-11 English
Appendix 2A 9 pages 193.8KB
Regulatory Filings
2021-05-11 English
Regeneus Announces Institutional Placement 4 pages 149.4KB
Capital/Financing Update
2021-05-06 English
Proposed issue of Securities - RGS 8 pages 35.8KB
Capital/Financing Update
2021-05-06 English
Grant of Options to CEO and Appendix 3G 13 pages 379.1KB
Share Issue/Capital Change
2021-05-04 English
Appendix 4C - Quarterly 8 pages 332.3KB
Interim / Quarterly Report
2021-04-29 English
Regeneus partners with Defence to treat combat casualties 2 pages 141.2KB
Capital/Financing Update
2021-04-28 English
Regeneus to be granted key Progenza patent in Europe 1
Regulatory Filings
2021-03-15 English
Regeneus Company Update Investor Webcast Presentation 26 pages 1.2MB
Investor Presentation
2021-03-02 English
Appendix 3Z Final Director's Interest Notice Dr Alan Dunton 2 pages 218.7KB
Director's Dealing
2021-02-28 English
Appendix 4D and Half-Year Report 22 pages 1.2MB
Interim / Quarterly Report
2021-02-25 English
Half-Year Results and Business Update 4 pages 163.9KB
Interim / Quarterly Report
2021-02-25 English
Resignation of Non Executive Director Dr Alan Dunton 1
Board/Management Information
2021-02-24 English
Regeneus Company Update Investor Webcast Notification 1
Investor Presentation
2021-02-24 English
Regeneus to be granted new patent to target pain in Japan 2 pages 144.4KB
Regulatory Filings
2021-02-08 English
Clarification on Quarterly Activity Report and Appendix 4C 1
Regulatory Filings
2021-02-04 English
Response to ASX Appendix 4C Query 4 pages 334.2KB
Regulatory Filings
2021-02-04 English
Appendix 4C - Quarterly Report 8 pages 325.5KB
Interim / Quarterly Report
2021-01-28 English